Heart 1997;78:323-324 ( October )
Editorial
Transferring patients for primary angioplasty
| The first 150 words of the full text of this article appear below. |
The success of fibrinolysis in the treatment of myocardial
infarction has been attributed to reperfusion of the occluded vessel, however, it has become clear that it is not just reperfusion but restoration of normal flow
defined angiographically as TIMI-3 flow
in
the infarct related artery that dictates mortality. Analysis of the
different treatment arms of GUSTO-I,1 the PAMI
trials,2,3 and the primary angioplasty
registry,4 demonstrates a very clear inverse linear
relation between mortality and the rate of TIMI-3 flow achieved in the
infarct related artery. The randomised trials of primary angioplasty in
acute infarction2,5,6 all point to it being superior to
thrombolytic therapy in achieving this goal, although in the GUSTO-IIB
substudy7 the benefit was less marked.
The trials of thrombolytic therapy versus placebo all demonstrated a
time dependent benefit, the shortest "pain to needle" times having
the lowest mortality with a cut off at approximately six hours. This
has
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
